Group One Trading’s Neumora Therapeutics NMRA Stock Holding History

Group One Trading’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$413K	Buy	242,900 +206,400	+565%	+$393K	﹤0.01%	3666
2026 Q1	$71.2K	Sell	36,500 -536,000	-94%	-$1.39M	﹤0.01%	5001
2025 Q4	$1.02M	Buy	572,500 +526,800	+1,153%	+$1.15M	﹤0.01%	2866
2025 Q3	$83.2K	Buy	45,700 +8,200	+22%	+$13.3K	﹤0.01%	5512
2025 Q2	$27.5K	Sell	37,500 -11,000	-23%	-$8.33K	﹤0.01%	6061
2025 Q1	$48.5K	Sell	48,500 -48,000	-50%	-$82.2K	﹤0.01%	5187
2024 Q4	$1.02M	Buy	96,500 +66,900	+226%	+$802K	﹤0.01%	2554
2024 Q3	$391K	Buy	+29,600	New	+$345K	﹤0.01%	3048

Other funds holding NMRA

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Group One Trading's NMRA Position: Q2 2026 in Review

Group One Trading reduced its Neumora Therapeutics (NMRA) stake by 3.4% in Q2 2026, selling an estimated $2.99K and leaving 44,471 shares worth $75.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5082.

Group One Trading first reported a position in NMRA in Q3 2024 and has held it in 3 quarters since. The position peaked at $208K in Q3 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

Group One Trading held 44,471 shares of Neumora Therapeutics worth $75.6K as of Q2 2026.
Group One Trading sold 1,571 Neumora Therapeutics shares in Q2 2026, an estimated $2.99K.
Neumora Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5082 holding.
Group One Trading first reported a position in Neumora Therapeutics in Q3 2024 and has held it in 3 quarters since.
Group One Trading's Neumora Therapeutics position peaked at $208K in Q3 2024.
113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.